ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 38 filers reported holding ATYR PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,565,445 | -38.9% | 1,171,436 | -16.3% | 0.43% | -33.3% |
| Q3 2022 | $4,197,000 | +6.0% | 1,398,889 | 0.0% | 0.65% | -16.9% |
| Q2 2022 | $3,959,000 | -47.1% | 1,398,889 | 0.0% | 0.78% | -35.6% |
| Q1 2022 | $7,484,000 | -36.0% | 1,398,889 | -10.6% | 1.21% | -24.2% |
| Q4 2021 | $11,691,000 | -17.7% | 1,565,000 | 0.0% | 1.60% | -12.4% |
| Q3 2021 | $14,210,000 | – | 1,565,000 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 725,984 | $3,223,000 | 0.05% |
| Marquette Asset Management, LLC | 18,848 | $84,000 | 0.03% |
| FEDERATED HERMES, INC. | 1,615,000 | $7,171,000 | 0.02% |
| VIKING GLOBAL INVESTORS LP | 587,444 | $2,608,000 | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 132,123 | $587,000 | 0.00% |
| OPPENHEIMER & CO INC | 18,343 | $81,000 | 0.00% |
| Renaissance Technologies | 365,830 | $1,624,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 80,950 | $359,000 | 0.00% |
| FMR LLC | 1,402,874 | $6,229,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 67,964 | $302,000 | 0.00% |